DES PLAINES, Illinois, January 13 /PRNewswire/ --

European clinicians will have a new weapon to combat cervical cancer with the introduction of Abbott Molecular's real-time polymerase chain reaction (PCR) based diagnostic test for human papillomavirus (HPV). The CE-marked assay can identify patients infected with specific viral genotypes known to pose the highest risk for progression to cervical cancer.

LAS VEGAS, January 13 /PRNewswire/ --

- Improves speed and economics of sophisticated analytics within large, data-intensive environments

Vertica Systems, Inc. announced today that MicroStrategy(R) Incorporated, a leading worldwide provider of business intelligence software, has certified MicroStrategy 8 to work with the Vertica(R) Analytic Database. Vertica can now offer MicroStrategy customers a fast, economical way to rapidly deploy teramarts that support new BI initiatives by extending information locked within enterprise data warehouses (EDWs) to more people so businesses can increase data-driven decision making at more levels and across more operational fronts.

AMSTERDAM, Netherlands, January 13 /PRNewswire/ --

- Online Identity Protection Products and Intellectual Property Extensions Strengthen AVG's Suite of Security Software Solutions, Marks AVG's Entrance into Silicon Valley

FRANKLIN, Wisconsin, January 13 /PRNewswire/ --

VUANCE, Ltd. (Nasdaq: VUNC), a leading provider of innovative Radio Frequency Verification Solutions, including active RFID, electronic access control, credentialing, accountability and incident response management, today announced that it has been selected to monitor and control all activity in the Decker Lake Youth Complex, in West Valley City, Utah. This is a correctional facility designed for housing youth in a Medium/High security setting.

LONDON, January 13 /PRNewswire/ --

The European heart health ingredients market is developing lucratively due to the growth in the functional foods sector, triggered by a global fitness fad among consumers. Extensive media coverage has heightened consumer awareness about the fatality of cardiovascular disease (CVD) and the ill effects of obesity, heightening interest towards low fat and heart-healthy food products.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost Sullivan (http://www.food.frost.com), European Heart Health Ingredients Market, finds that the market earned revenues of $545.0 million in 2008 and estimates this to reach $2.0 billion in 2014.

LONDON, January 13 /PRNewswire/ -- Unite, the largest trade union in the country, is suspending its industrial action over the imposed three-year NHS pay deal.

A joint meeting of Unite's Health Sector National Industrial Committee - attended by representatives from both the Amicus and TGWU sections - decided to defer industrial action on the pay campaign.

Unite now intends to concentrate on other aspects of the overall pay strategy, such as boosting the authority of the Staff Council, collating evidence for future pay claims, broadening the remit of the Pay Review Body (PRB), and specific employment issues, such as the recruitment and retention of pharmacists in the NHS.

NEW YORK, January 13 /PRNewswire/ --

Selerant ( www.selerant.com ) announces the extension of its relationship with Nestle in the area of the lifecycle management solution DevEX.

This further expansion of the DevEX 2.0 release will include the latest enhancements and features, a simple but robust regulatory compliance management system.

The solution provides multi-level transparency on all the recipes' lifecycles, using a graphical layout. Users will have the ability to quickly drill down into the details and easily zoom back out to the big picture. Users will also be able to take advantage of the entirely new nutritional claims and labeling sub-systems. The product is built on the new Microsoft .NET Framework platform.

About Selerant

MAIDENHEAD, England, January 13 /PRNewswire/ --

- Prevenar Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children Worldwide

Turkey has initiated a national immunization programme (NIP) against pneumococcal disease with Wyeth's Prevenar(TM) (Pneumococcal saccharide conjugated vaccine, Adsorbed) - a vaccine which helps protect infants and young children against the seven serotypes causing the majority of pneumococcal disease worldwide. There are now more than 30 countries that include Prevenar in their childhood NIP.

GENEVA, Switzerland, January 13 /PRNewswire/ --

- Merck Serono and Apitope to Collaborate on Development and Commercialization of ATX-MS-1467, Apitope's Peptide Therapeutic for the Treatment of Multiple Sclerosis (MS)

UPPSALA, Sweden, January 13 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today announced a new research collaboration agreement with GE Healthcare (Chalfont St. Giles, UK), the world leading provider of molecular interaction analysis tools, and Uppsala University (Sweden). The collaboration combines Beactica's unique approach to fragment-based drug discovery and GE Healthcare's Biacore(TM) technology with enzymology expertise from Uppsala University.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090113/333930 )